Skip Navigation

JNCI Journal of the National Cancer Institute 1989 81(24):1917-1921; doi:10.1093/jnci/81.24.1917
© 1989 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Törnberg, S. A.
Right arrow Articles by Eklund, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Törnberg, S. A.
Right arrow Articles by Eklund, G. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 81, No. 24, 1917-1921, December 20, 1989
© 1989 Oxford University Press

Cancer Incidence and Cancer Mortality in Relation to Serum Cholesterol

Sven A. Törnberg*,, Lars-Erik Holm, John M. Carstensen, Gunnar A. Eklund

Department of General On-cology, Karolinska Hospital Stockholm, Sweden
Cancer Prevention, Karolinska Hospital Stockholm, Sweden
Cancer Epidemiology, Radiumhemmet, Karolinska Hospital Stockholm, Sweden
Department of Oncology, University Hospital Linköping, Sweden

*Correspondence to: Sven A. Törnberg, M.D., Department of General Oncology, Radiumhem-met, Karolinska Hospital, S-104 01 Stockholm, Sweden.

We studied cancer incidence and mortality from cancer and coronary heart disease in relation to serum cholesterol levels in 92, 710 individuals followed-up in the nationwide Swedish Cancer Register and the Swedish Cause of Death Register for 18–20 years. According to Cox's proportional hazard model, total cancer incidence and total cancer mortality were negatively correlated to serum cholesterol level (P<.001). The negative correlations were most pronounced during the first years of follow-up. Cancer mortality data showed a stronger negative association to cholesterol than did incidence data during the first 10 years of follow-up (P<.05). Mortality from coronary heart disease was positively correlated to serum cholesterol (P<.001) during the entire follow-up. In contrast to most studies that were based on mortality data, our results of the comparison of incidence and mortality data of the same cohort are in agreement with those of a cholesterol-lowering effect of a preclinical cancer. Efforts by investigators and clinicians to lower serum cholesterol to prevent cardiovascular disease are, according to the present findings, not likely to increase cancer mortality risks but would extend life, irrespective of cause of death. [J Natl Cancer Inst 81: 1917–1921, 1989].


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
A. M. Strasak, R. M. Pfeiffer, L. J. Brant, K. Rapp, W. Hilbe, W. Oberaigner, S. Lang, W. Borena, H. Concin, G. Diem, et al.
Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study
Ann. Onc., June 1, 2009; 20(6): 1113 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. Steinberg
Statin Treatment Does Not Cause Cancer
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1148 - 1149.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. B. Panagiotakos, C. Pitsavos, E. Polychronopoulos, C. Chrysohoou, A. Menotti, A. Dontas, and C. Stefanadis
Total Cholesterol and Body Mass Index in Relation to 40-Year Cancer Mortality (The Corfu Cohort of the Seven Countries Study)
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1797 - 1801.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Eichholzer, H. B Stahelin, F. Gutzwiller, E. Ludin, and F. Bernasconi
Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study1
Am. J. Clinical Nutrition, February 1, 2000; 71(2): 569 - 574.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Iribarren, D. M. Reed, R. Chen, K. Yano, and J. H. Dwyer
Low Serum Cholesterol and Mortality : Which Is the Cause and Which Is the Effect?
Circulation, November 1, 1995; 92(9): 2396 - 2403.
[Abstract] [Full Text]

Home page
 CirculationHome page
A. M. Gotto Jr
Lipid Lowering, Regression, and Coronary Events : A Review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council Meeting
Circulation, August 1, 1995; 92(3): 646 - 656.
[Full Text]

Home page
 BMJHome page
M R Law, N J Wald, and S G Thompson
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
BMJ, February 5, 1994; 308(6925): 367 - 372.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
J. D. Neaton, H. Blackburn, D. Jacobs, L. Kuller, D.-J. Lee, R. Sherwin, J. Shih, J. Stamler, and D. Wentworth
Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
Arch Intern Med, July 1, 1992; 152(7): 1490 - 1500.
[Abstract] [PDF]

Home page
 JAMAHome page
G. D. Smith, M. J. Shipley, M. G. Marmot, and G. Rose
Plasma Cholesterol Concentration and Mortality: The Whitehall Study
JAMA, January 1, 1992; 267(1): 70 - 76.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.